









Markets
/
Stocks
/
nasdaq-pntg
/

Pennant Group Inc

PNTG

24.760USD

+0.400+1.64%

Close 09/18, 16:00（ET）Quotes delayed by 15 min

853.97MMarket Cap

31.84P/E TTM



Pennant Group Inc

24.760

+0.400+1.64%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated：2025-09-18

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

13 / 72

Overall Ranking

97 / 4721

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 5 analysts

Buy

Current Rating

33.600

Target Price

+37.93%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through home health and hospice agencies and senior living communities located throughout Arizona, California, Colorado, Connecticut, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. Each of these businesses is operated by a separate, independent operating subsidiary that has its own management, employees and assets. Its segments include home health and hospice services, and senior living services. The home health and hospice services segment includes its home health, hospice and home care businesses. Its home health services provide care after surgery or when illness or health conditions require additional assistance. The senior living services segment includes the operation of assisted living, independent living and memory care communities. Its independent living communities are designed for active individuals or couples.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 46.91% year-on-year.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 239.59.

Undervalued

The company’s latest PE is 30.88, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 33.51M shares, decreasing 2.28% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 2.09M shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.89.

Financial Health

Currency: USD Updated：2025-09-18

The company's current financial score is 8.48, which is higher than the Healthcare Providers & Services industry's average of 7.42. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 219.50M, representing a year-over-year increase of 30.08%, while its net profit experienced a year-over-year increase of 24.52%.

Score

Industry at a Glance

Previous score

8.48

Change



Financials

5.44

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

10.00

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

9.34

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.63

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated：2025-09-18

The company’s current valuation score is 4.27, which is higher than the Healthcare Providers & Services industry's average of 2.35. Its current P/E ratio is 30.38, which is 55.54% below the recent high of 47.25 and -10.77% above the recent low of 33.65.

Score

Industry at a Glance

Previous score

4.27

Change

-0.04

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 13/72

No Data

Earnings Forecast

Currency: USD Updated：2025-09-18

The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Providers & Services industry's average of 7.58. The average price target for Pennant Group Inc is 34.00, with a high of 40.00 and a low of 28.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 5 analysts

Buy

Current Rating

33.600

Target Price

+37.93%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Pennant Group Inc

PNTG

CVS Health Corp

CVS

HCA Healthcare Inc

HCA

Teladoc Health Inc

TDOC

Tenet Healthcare Corp

THC

Natera Inc

NTRA

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated：2025-09-18

The company’s current price momentum score is 6.82, which is lower than the Healthcare Providers & Services industry's average of 6.88. Sideways: Currently, the stock price is trading between the resistance level at 25.76 and the support level at 23.30, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.82

Change

0.27

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(3)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.023

Buy

RSI(14)

50.425

Neutral

STOCH(KDJ)(9,3,3)

43.063

Sell

ATR(14)

0.815

High Vlolatility

CCI(14)

-11.645

Neutral

Williams %R

54.878

Neutral

TRIX(12,20)

0.072

Sell

StochRSI(14)

32.731

Buy

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

24.906

Sell

MA10

24.847

Sell

MA20

24.641

Buy

MA50

24.283

Buy

MA100

26.163

Sell

MA200

26.208

Sell

Institutional Confidence

Currency: USD Updated：2025-09-18

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Providers & Services industry's average of 8.03. The latest institutional shareholding proportion is 96.97%, representing a quarter-over-quarter increase of 1.30%. The largest institutional shareholder is The Vanguard, holding a total of 2.09M shares, representing 6.04% of shares outstanding, with 7.89% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Fidelity Management & Research Company LLC

3.72M

+4.42%

Van Berkom & Associates Inc.

2.85M

+29.63%

8 knots Management LLC

3.01M

+23.90%

BlackRock Institutional Trust Company, N.A.

2.38M

+4.65%

The Vanguard Group, Inc.

Star Investors

2.12M

-5.97%

Paradigm Capital Management, Inc.

955.00K

+1.70%

Geode Capital Management, L.L.C.

796.12K

+3.71%

Riverbridge Partners, LLC

928.61K

-8.08%

State Street Global Advisors (US)

735.85K

+2.93%

Risk Assessment

Currency: USD Updated：2025-09-18

The company’s current risk assessment score is 4.60, which is higher than the Healthcare Providers & Services industry's average of 4.17. The company's beta value is 1.35. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.